Alvotech reports first half 2022 financial results and business update

Reykjavik, iceland, aug. 31, 2022 (globe newswire) -- alvotech (nasdaq: alvo, or the “company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today reported financial results for the first half of 2022 and provided a summary of recent corporate highlights. the company also filed the interim financial statements with the icelandic stock exchange for the first six months of 2022, in accordance with the nasdaq first north rulebook.
ALVO Ratings Summary
ALVO Quant Ranking